Bioinformatics Analysis of ZBTB16 as a Prognostic Marker for Ewing's Sarcoma

CONCLUSIONS: High expression of ZBTB16 may serve as a predictor biomarker of poor prognosis in ES patients.PMID:34660783 | PMC:PMC8514890 | DOI:10.1155/2021/1989917
Source: Biomed Res - Category: Research Authors: Source Type: research